Core Viewpoint - The Trump administration has been hesitant to lower tariffs on fentanyl-based products imported from Beijing, indicating a cautious approach towards trade relations with China [1] Group 1 - The reluctance to reduce tariffs reflects ongoing tensions between the U.S. and China regarding trade policies and drug-related issues [1]